User profiles for Ludmila Rodrigues Pinto Ferreira

Ludmila Rodrigues P. Ferreira

Universidade Federal de Minas Gerais
Verified email at icb.ufmg.br
Cited by 1454

MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy

LRP Ferreira, AF Frade, RHB Santos… - International journal of …, 2014 - Elsevier
Background/methods Chagas disease is caused by an intracellular parasite, Trypanosoma
cruzi, and it is a leading cause of heart failure in Latin America. The main clinical …

[HTML][HTML] Exosomes from patients with septic shock convey miRNAs related to inflammation and cell cycle regulation: new signaling pathways in sepsis?

JM Real, LRP Ferreira, GH Esteves, FC Koyama… - Critical Care, 2018 - Springer
Background Exosomes isolated from plasma of patients with sepsis may induce vascular
apoptosis and myocardial dysfunction by mechanisms related to inflammation and oxidative …

[HTML][HTML] MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes

IC Navarro, FM Ferreira, HI Nakaya… - PLoS neglected …, 2015 - journals.plos.org
Chagas disease is caused by the parasite Trypanosoma cruzi, and it begins with a short
acute phase characterized by high parasitemia followed by a life-long chronic phase with …

[HTML][HTML] miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy

L Laugier, LRP Ferreira, FM Ferreira… - PLoS neglected …, 2020 - journals.plos.org
Chronic Chagas disease cardiomyopathy (CCC), an especially aggressive inflammatory
dilated cardiomyopathy caused by lifelong infection with the protozoan Trypanosoma cruzi, is a …

Whole-genome cardiac DNA methylation fingerprint and gene expression analysis provide new insights in the pathogenesis of chronic Chagas disease …

L Laugier, AF Frade, FM Ferreira… - Clinical Infectious …, 2017 - academic.oup.com
Background Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in
Latin America and affects 10 million people worldwide. Approximately 12000 deaths …

[HTML][HTML] Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy

LRP Ferreira, AF Frade, MA Baron… - World journal of …, 2014 - ncbi.nlm.nih.gov
Chagas disease cardiomyopathy (CCC), the main consequence of Trypanosoma cruzi (T.
cruzi) infection, is an inflammatory cardiomyopathy that develops in up to 30% of infected …

[HTML][HTML] Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute Trypanosoma cruzi infection

LRP Ferreira, FM Ferreira, L Laugier, S Cabantous… - Scientific Reports, 2017 - nature.com
Chagas disease, caused by the parasite Trypanosoma cruzi, is endemic in Latin America. Its
acute phase is associated with high parasitism, myocarditis and profound myocardial gene …

Myocardial infarction–associated transcript, a long noncoding RNA, is overexpressed during dilated cardiomyopathy due to chronic chagas disease

AF Frade, L Laugier, LRP Ferreira… - The Journal of …, 2016 - academic.oup.com
Long noncoding RNAs (lncRNAs) modulate gene expression at the epigenetic, transcriptional,
and posttranscriptional levels. Dysregulation of the lncRNA known as myocardial …

[HTML][HTML] Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration …

…, AC Pereira, E Donadi, J Kalil, V Rodrigues… - BMC infectious …, 2013 - Springer
Background Chagas disease, caused by the protozoan Trypanosoma cruzi is endemic in
Latin America. Thirty percent of infected individuals develop chronic Chagas cardiomyopathy (…

Blood gene signatures of Chagas cardiomyopathy with or without ventricular dysfunction

LRP Ferreira, FM Ferreira, HI Nakaya… - The Journal of …, 2017 - academic.oup.com
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects 7 million
people in Latin American areas of endemicity. About 30% of infected patients will develop …